Central Review of ER, PgR and HER2 in BIG 1-98 Evaluating Letrozole vs. Letrozole Followed by Tamoxifen vs. Tamoxifen Followed by Letrozole as Adjuvant Endocrine Therapy for Postmenopausal Women with Hormone Receptor-Positive Breast Cancer

Central Review of ER, PgR and HER2 in BIG 1-98 Evaluating Letrozole vs. Letrozole Followed by Tamoxifen vs. Tamoxifen Followed by Letrozole as Adjuvant Endocrine Therapy for Postmenopausal Women with Hormone Receptor-Positive Breast Cancer / Viale, G; Regan, Mm; Dell'Orto, P; Mastropasqua, Mg; Rasmussen, Bb; Macgrogan, G; Braye, S; Orosz, Z; Giobbie-Hurder, A; Neven, P; Knox, F; Oehlschlegel, C; Thuerlimann, B; Coates, As; Goldhirsch, A. - In: CANCER RESEARCH. - ISSN 0008-5472. - 69:24(2009), pp. 504S-504S.